FDA Inspection
CSL Plasma Inc.CSL Plasma Inc. – FDA Inspection, Feb 12, 2020
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on February 12, 2020, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CSL Plasma Inc.
- Inspection Date
- February 12, 2020
- Product Type
- Biologics
View Company Profile
ID · b964c9ac-745b-410c-8e6d-6f8deace5107
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1117599
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 630.10(c)Donor Eligibility on day of donation
- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2021 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 16, 2017 | Not classified | Minneapolis District Office |
Other documents for CSL Plasma Inc.
- FDA Inspection 1148848 - 2021-08-03
- FDA Inspection 1014058 - 2017-05-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.